Policy | December 16, 2025
Pharma overhaul: EMA hails “Once-in-a-Generation” reform
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
Her journey includes leading HR for large and diverse teams across sales, marketing, corporate functions, and R&D
The positive CHMP opinion is supported by results from the Phase III QUASAR trial
WINREVAIR is currently the first and only activin signalling inhibitor approved for PAH across all 27 EU member states
This is the first approval of a prescription transdermal dosage Form in the European markets from this facility
The patented product, developed by Venus Medicine Research Centre (VMRC) for the treatment of multidrug-resistant (MDR) infections, was sold to Cipla in 2019
The study met its primary endpoint and all 11 secondary efficacy endpoints
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
MRI is particularly valuable in pediatric care due to its non-invasive nature
Subscribe To Our Newsletter & Stay Updated
